Jul 21, 2023· Comment from Association for Accessible Medicines (AAM)· FDA-2023-N-0573-0017
FDA, Please find attached comments from The Association for Accessible Medicines (AAM) regarding Docket No. FDA-2023-N-0573: "Changes to Third-Party Vendors for Risk Evaluation and Mitigation Strategies" Thanks, Scott Kuzner, Ph.D., Senior Director, Sciences and Regulatory Affairs Association for Accessible Medicines (AAM)